InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
RNAC
Result 168 decisions over 120 months
Reset filters
Direction ?
Both168 Bought87 Sold81
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: RNAC
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
RNAC Cartesian Therapeutics, Inc.
26 May 2021
SPRINGER TIMOTHY A
Director indirect
Bought
926,170
$3.71M
5.1%
RNAC Cartesian Therapeutics, Inc.
26 May 2021
TRABER PETER G
Chief Medical Officer
Bought
20,000
$79.85K
17.3%
RNAC Cartesian Therapeutics, Inc.
25 May 2021
SPRINGER TIMOTHY A
Director indirect
Bought
383,830
$1.36M
2.2%
RNAC Cartesian Therapeutics, Inc.
25 May 2021
TRABER PETER G
Chief Medical Officer
Bought
5,000
$17.40K
4.5%
RNAC Cartesian Therapeutics, Inc.
24 May 2021
SPRINGER TIMOTHY A
Director indirect
Bought
590,000
$1.99M
3.4%
RNAC Cartesian Therapeutics, Inc.
24 May 2021
TRABER PETER G
Chief Medical Officer
Bought
12,500
$41.50K
12.8%
RNAC Cartesian Therapeutics, Inc.
21 May 2021
SPRINGER TIMOTHY A
Director indirect
Bought
2,773,479
$8.85M
19.2%
RNAC Cartesian Therapeutics, Inc.
26 Mar 2021
BARABE TIMOTHY C
Director
Bought
10,000
$41.00K
5.8%
RNAC Cartesian Therapeutics, Inc.
18 Mar 2021
TRABER PETER G
Chief Medical Officer
Bought
10,000
$45.00K
11.4%
RNAC Cartesian Therapeutics, Inc.
17 Mar 2021
Johnston Lloyd P.
COO and SVP, R&D
Sold, plan not stated
15,128
$67.31K
14.7%
RNAC Cartesian Therapeutics, Inc.
17 Mar 2021
TRABER PETER G
Chief Medical Officer
Bought
10,000
$45.30K
12.8%
RNAC Cartesian Therapeutics, Inc.
2 Mar 2021
Brunn Carsten
President and CEO
Sold, plan not stated
5,461
$23.26K
2.5%
RNAC Cartesian Therapeutics, Inc.
14 Dec 2020
TRABER PETER G
Chief Medical Officer
Bought
40,000
$129.42K
opened
RNAC Cartesian Therapeutics, Inc.
2 Dec 2020
Brunn Carsten
President and CEO
Sold, plan not stated
3,323
$11.13K
3.2%
RNAC Cartesian Therapeutics, Inc.
23 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
994,488
$2.70M
7.4%
RNAC Cartesian Therapeutics, Inc.
22 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
1,770,204
$4.66M
15.1%
RNAC Cartesian Therapeutics, Inc.
21 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
880,000
$2.20M
8.1%
RNAC Cartesian Therapeutics, Inc.
20 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
910,000
$2.01M
9.2%
RNAC Cartesian Therapeutics, Inc.
19 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
759,500
$1.80M
8.3%
RNAC Cartesian Therapeutics, Inc.
16 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
218,196
$528.03K
2.4%
RNAC Cartesian Therapeutics, Inc.
9 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
276,703
$552.47K
3.2%
RNAC Cartesian Therapeutics, Inc.
8 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
530,441
$1.00M
6.5%
RNAC Cartesian Therapeutics, Inc.
7 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
654,953
$1.08M
8.7%
RNAC Cartesian Therapeutics, Inc.
6 Oct 2020
SPRINGER TIMOTHY A
Director indirect
Bought
2,000,000
$3.37M
36.5%
RNAC Cartesian Therapeutics, Inc.
6 Oct 2020
BARABE TIMOTHY C
Director
Bought
50,000
$83.99K
41.3%
RNAC Cartesian Therapeutics, Inc.
2 Sep 2020
Brunn Carsten
President and CEO
Sold, plan not stated
3,364
$8.03K
3.5%
RNAC Cartesian Therapeutics, Inc.
2 Jun 2020
Brunn Carsten
President and CEO
Sold, plan not stated
3,253
$12.56K
3.6%
RNAC Cartesian Therapeutics, Inc.
17 Mar 2020
BARABE TIMOTHY C
Director
Bought
5,000
$10.00K
6.0%
RNAC Cartesian Therapeutics, Inc.
3 Mar 2020
Brunn Carsten
President and CEO
Sold, plan not stated
3,374
$13.01K
4.1%
RNAC Cartesian Therapeutics, Inc.
2 Dec 2019
Brunn Carsten
President and CEO
Sold, plan not stated
14,272
$21.81K
16.8%
RNAC Cartesian Therapeutics, Inc.
14 Aug 2019
SPRINGER TIMOTHY A
Director indirect
Bought
10,000
$17.42K
13.1%
RNAC Cartesian Therapeutics, Inc.
13 Aug 2019
BARABE TIMOTHY C
Director
Bought
10,000
$17.20K
133%
RNAC Cartesian Therapeutics, Inc.
25 Jan 2019
SPRINGER TIMOTHY A
Director
Bought
4,000,000
$6.00M
876%
RNAC Cartesian Therapeutics, Inc.
25 Jan 2019
Nashat Amir
Director indirect
Bought 4×
1,166,666
$1.75M
77.3%
RNAC Cartesian Therapeutics, Inc.
25 Jan 2019
Farokhzad Omid
Director indirect
Bought
83,333
$125.00K
opened
RNAC Cartesian Therapeutics, Inc.
25 Jan 2019
SPRINGER TIMOTHY A
Director indirect
Bought
66,666
$100.00K
684%
RNAC Cartesian Therapeutics, Inc.
17 Nov 2017
Sands Earl
Chief Medical Officer
Bought
7,500
$76.97K
opened
RNAC Cartesian Therapeutics, Inc.
14 Nov 2017
SPRINGER TIMOTHY A
Director
Bought
57,598
$534.09K
14.3%
RNAC Cartesian Therapeutics, Inc.
14 Nov 2017
Abraham David
GC, CCO & Corporate Secretary
Bought
5,405
$50.00K
opened
RNAC Cartesian Therapeutics, Inc.
13 Nov 2017
CAUTREELS WERNER
President and CEO
Bought
20,000
$186.25K
6.6%
RNAC Cartesian Therapeutics, Inc.
10 Nov 2017
SPRINGER TIMOTHY A
Director
Bought 2×
26,338
$238.10K
7.0%
RNAC Cartesian Therapeutics, Inc.
10 Nov 2017
SPRINGER TIMOTHY A
Director indirect
Bought
4,752
$42.91K
95.0%
RNAC Cartesian Therapeutics, Inc.
10 Nov 2017
BARABE TIMOTHY C
Director
Bought
2,500
$22.50K
50.1%
RNAC Cartesian Therapeutics, Inc.
9 Nov 2017
SPRINGER TIMOTHY A
Director
Bought 2×
22,000
$205.66K
6.2%
RNAC Cartesian Therapeutics, Inc.
9 Nov 2017
SPRINGER TIMOTHY A
Director indirect
Bought 2×
5,000
$46.68K
opened
RNAC Cartesian Therapeutics, Inc.
9 Nov 2017
BARABE TIMOTHY C
Director
Bought
2,500
$24.34K
100%
RNAC Cartesian Therapeutics, Inc.
26 Sep 2017
Nashat Amir
Director indirect
Sold, plan not stated 4×
70,226
$1.33M
86.9%
RNAC Cartesian Therapeutics, Inc.
25 Sep 2017
Nashat Amir
Director indirect
Sold, plan not stated 4×
37,175
$705.88K
77.0%
RNAC Cartesian Therapeutics, Inc.
22 Sep 2017
Nashat Amir
Director indirect
Sold, plan not stated 4×
42,036
$809.78K
78.8%
RNAC Cartesian Therapeutics, Inc.
21 Sep 2017
Nashat Amir
Director indirect
Sold, plan not stated 4×
104,577
$2.08M
90.0%
Showing 101–150 of 168. ← Newer Page 3 of 4 Older →